Animalcare Group (ANCR) Competitors GBX 332.06 +0.56 (+0.17%) As of 11:18 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ANCR vs. AGY, AMYT, APH, BXP, and STXShould you buy Animalcare Group stock or one of its competitors? MarketBeat compares Animalcare Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Animalcare Group include Allergy Therapeutics (AGY), Amryt Pharma (AMYT), Alliance Pharma (APH), Beximco Pharmaceuticals (BXP), and Shield Therapeutics (STX). These companies are all part of the "drug manufacturers - specialty & generic" industry. ANCR vs. AGYANCR vs. AMYTANCR vs. APHANCR vs. BXPANCR vs. STXHow does Animalcare Group compare to Allergy Therapeutics?Animalcare Group (LON:ANCR) and Allergy Therapeutics (LON:AGY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation. Do insiders & institutionals hold more shares of ANCR or AGY? 16.1% of Animalcare Group shares are held by institutional investors. Comparatively, 0.0% of Allergy Therapeutics shares are held by institutional investors. 30.1% of Animalcare Group shares are held by company insiders. Comparatively, 3.5% of Allergy Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is ANCR or AGY more profitable? Animalcare Group has a net margin of 5.70% compared to Allergy Therapeutics' net margin of -85.46%. Allergy Therapeutics' return on equity of 409.00% beat Animalcare Group's return on equity.Company Net Margins Return on Equity Return on Assets Animalcare Group5.70% 4.46% 2.97% Allergy Therapeutics -85.46%409.00%-34.76% Does the media refer more to ANCR or AGY? In the previous week, Animalcare Group and Animalcare Group both had 1 articles in the media. Animalcare Group's average media sentiment score of 0.75 beat Allergy Therapeutics' score of 0.67 indicating that Animalcare Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Animalcare Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Allergy Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings & valuation, ANCR or AGY? Animalcare Group has higher revenue and earnings than Allergy Therapeutics. Allergy Therapeutics is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnimalcare Group£81.07M2.83£36.55M£3.6092.24Allergy Therapeutics£57.29M10.72-£52.59M-£0.97N/A Which has more risk & volatility, ANCR or AGY? Animalcare Group has a beta of 0.694, indicating that its stock price is 31% less volatile than the broader market. Comparatively, Allergy Therapeutics has a beta of 0.891, indicating that its stock price is 11% less volatile than the broader market. SummaryAnimalcare Group beats Allergy Therapeutics on 9 of the 12 factors compared between the two stocks.How does Animalcare Group compare to Amryt Pharma?Animalcare Group (LON:ANCR) and Amryt Pharma (LON:AMYT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability. Which has stronger earnings & valuation, ANCR or AMYT? Animalcare Group has higher earnings, but lower revenue than Amryt Pharma. Amryt Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnimalcare Group£81.07M2.83£36.55M£3.6092.24Amryt Pharma£210.24M0.00N/A-£33.00N/A Do institutionals & insiders believe in ANCR or AMYT? 16.1% of Animalcare Group shares are held by institutional investors. 30.1% of Animalcare Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is ANCR or AMYT more profitable? Animalcare Group has a net margin of 5.70% compared to Amryt Pharma's net margin of 0.00%. Animalcare Group's return on equity of 4.46% beat Amryt Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Animalcare Group5.70% 4.46% 2.97% Amryt Pharma N/A N/A N/A Does the media favor ANCR or AMYT? In the previous week, Animalcare Group had 1 more articles in the media than Amryt Pharma. MarketBeat recorded 1 mentions for Animalcare Group and 0 mentions for Amryt Pharma. Animalcare Group's average media sentiment score of 0.75 beat Amryt Pharma's score of 0.00 indicating that Animalcare Group is being referred to more favorably in the media. Company Overall Sentiment Animalcare Group Positive Amryt Pharma Neutral SummaryAnimalcare Group beats Amryt Pharma on 9 of the 10 factors compared between the two stocks.How does Animalcare Group compare to Alliance Pharma?Animalcare Group (LON:ANCR) and Alliance Pharma (LON:APH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends. Which has better earnings & valuation, ANCR or APH? Animalcare Group has higher earnings, but lower revenue than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnimalcare Group£81.07M2.83£36.55M£3.6092.24Alliance Pharma£183.50M1.91-£33.65M-£6.20N/A Which has more risk & volatility, ANCR or APH? Animalcare Group has a beta of 0.694, suggesting that its share price is 31% less volatile than the broader market. Comparatively, Alliance Pharma has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market. Is ANCR or APH more profitable? Animalcare Group has a net margin of 5.70% compared to Alliance Pharma's net margin of -6.00%. Animalcare Group's return on equity of 4.46% beat Alliance Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Animalcare Group5.70% 4.46% 2.97% Alliance Pharma -6.00%-5.04%5.98% Does the media refer more to ANCR or APH? In the previous week, Animalcare Group had 1 more articles in the media than Alliance Pharma. MarketBeat recorded 1 mentions for Animalcare Group and 0 mentions for Alliance Pharma. Animalcare Group's average media sentiment score of 0.75 beat Alliance Pharma's score of 0.00 indicating that Animalcare Group is being referred to more favorably in the media. Company Overall Sentiment Animalcare Group Positive Alliance Pharma Neutral Is ANCR or APH a better dividend stock? Animalcare Group pays an annual dividend of GBX 5 per share and has a dividend yield of 1.5%. Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 3.1%. Animalcare Group pays out 138.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Alliance Pharma pays out -32.2% of its earnings in the form of a dividend. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio. Do institutionals and insiders have more ownership in ANCR or APH? 16.1% of Animalcare Group shares are owned by institutional investors. Comparatively, 66.3% of Alliance Pharma shares are owned by institutional investors. 30.1% of Animalcare Group shares are owned by insiders. Comparatively, 12.0% of Alliance Pharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryAnimalcare Group beats Alliance Pharma on 10 of the 15 factors compared between the two stocks.How does Animalcare Group compare to Beximco Pharmaceuticals?Beximco Pharmaceuticals (LON:BXP) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends. Is BXP or ANCR more profitable? Beximco Pharmaceuticals has a net margin of 13.13% compared to Animalcare Group's net margin of 5.70%. Beximco Pharmaceuticals' return on equity of 12.72% beat Animalcare Group's return on equity.Company Net Margins Return on Equity Return on Assets Beximco Pharmaceuticals13.13% 12.72% 6.97% Animalcare Group 5.70%4.46%2.97% Which has more volatility and risk, BXP or ANCR? Beximco Pharmaceuticals has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.694, indicating that its share price is 31% less volatile than the broader market. Does the media refer more to BXP or ANCR? In the previous week, Animalcare Group had 1 more articles in the media than Beximco Pharmaceuticals. MarketBeat recorded 1 mentions for Animalcare Group and 0 mentions for Beximco Pharmaceuticals. Animalcare Group's average media sentiment score of 0.75 beat Beximco Pharmaceuticals' score of 0.00 indicating that Animalcare Group is being referred to more favorably in the news media. Company Overall Sentiment Beximco Pharmaceuticals Neutral Animalcare Group Positive Do institutionals and insiders have more ownership in BXP or ANCR? 1.2% of Beximco Pharmaceuticals shares are held by institutional investors. Comparatively, 16.1% of Animalcare Group shares are held by institutional investors. 4.2% of Beximco Pharmaceuticals shares are held by insiders. Comparatively, 30.1% of Animalcare Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has stronger earnings and valuation, BXP or ANCR? Beximco Pharmaceuticals has higher revenue and earnings than Animalcare Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeximco Pharmaceuticals£46.34B0.00£970.84B£1.43 thousand0.03Animalcare Group£81.07M2.83£36.55M£3.6092.24 Is BXP or ANCR a better dividend stock? Beximco Pharmaceuticals pays an annual dividend of GBX 396.85 per share and has a dividend yield of 933.8%. Animalcare Group pays an annual dividend of GBX 5 per share and has a dividend yield of 1.5%. Beximco Pharmaceuticals pays out 27.8% of its earnings in the form of a dividend. Animalcare Group pays out 138.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Beximco Pharmaceuticals is clearly the better dividend stock, given its higher yield and lower payout ratio. SummaryBeximco Pharmaceuticals beats Animalcare Group on 8 of the 15 factors compared between the two stocks.How does Animalcare Group compare to Shield Therapeutics?Shield Therapeutics (LON:STX) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations. Which has more volatility & risk, STX or ANCR? Shield Therapeutics has a beta of 1.877, suggesting that its stock price is 88% more volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.694, suggesting that its stock price is 31% less volatile than the broader market. Is STX or ANCR more profitable? Animalcare Group has a net margin of 5.70% compared to Shield Therapeutics' net margin of -34.53%. Shield Therapeutics' return on equity of 103.62% beat Animalcare Group's return on equity.Company Net Margins Return on Equity Return on Assets Shield Therapeutics-34.53% 103.62% -47.85% Animalcare Group 5.70%4.46%2.97% Do institutionals and insiders believe in STX or ANCR? 1.1% of Shield Therapeutics shares are owned by institutional investors. Comparatively, 16.1% of Animalcare Group shares are owned by institutional investors. 3.0% of Shield Therapeutics shares are owned by company insiders. Comparatively, 30.1% of Animalcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor STX or ANCR? In the previous week, Animalcare Group had 1 more articles in the media than Shield Therapeutics. MarketBeat recorded 1 mentions for Animalcare Group and 0 mentions for Shield Therapeutics. Animalcare Group's average media sentiment score of 0.75 beat Shield Therapeutics' score of 0.00 indicating that Animalcare Group is being referred to more favorably in the news media. Company Overall Sentiment Shield Therapeutics Neutral Animalcare Group Positive Which has preferable valuation and earnings, STX or ANCR? Animalcare Group has higher revenue and earnings than Shield Therapeutics. Shield Therapeutics is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShield Therapeutics£49.70M1.40-£36.28M-£2.00N/AAnimalcare Group£81.07M2.83£36.55M£3.6092.24 Do analysts rate STX or ANCR? Shield Therapeutics presently has a consensus target price of GBX 15, indicating a potential upside of 130.24%. Given Shield Therapeutics' stronger consensus rating and higher probable upside, equities research analysts plainly believe Shield Therapeutics is more favorable than Animalcare Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shield Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Animalcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAnimalcare Group beats Shield Therapeutics on 11 of the 16 factors compared between the two stocks. Get Animalcare Group News Delivered to You Automatically Sign up to receive the latest news and ratings for ANCR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANCR vs. The Competition ExportMetricAnimalcare GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£229.28M£2.12B£6.27B£2.79BDividend Yield1.57%2.96%2.80%6.16%P/E Ratio92.245.3920.85365.29Price / Sales2.831,678.37511.6887,514.55Price / Cash26.0510.1843.0927.89Price / Book2.0510.749.907.58Net Income£36.55M£20.70B£3.55B£5.89B7 Day Performance-0.04%-0.85%-0.30%0.20%1 Month Performance-0.13%-3.94%-2.34%0.88%1 Year Performance29.71%23.98%30.89%82.73% Animalcare Group Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANCRAnimalcare GroupN/AGBX 332.06+0.2%N/A+31.3%£229.28M£81.07M92.24220AGYAllergy TherapeuticsN/AGBX 9.98+0.8%N/A+37.5%£631.99M£57.29MN/A612News CoverageAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24MN/A290Gap DownAPHAlliance PharmaN/AGBX 64.70flatN/AN/A£350.32M£183.50MN/A91,000BXPBeximco PharmaceuticalsN/AGBX 42.50flatN/AN/A£189.60M£46.34B0.035,500 Related Companies and Tools Related Companies Allergy Therapeutics Alternatives Amryt Pharma Alternatives Alliance Pharma Alternatives Beximco Pharmaceuticals Alternatives Shield Therapeutics Alternatives Venture Life Group Alternatives ECO Animal Health Group Alternatives Diurnal Group Alternatives Provexis Alternatives Argent BioPharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ANCR) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredAre we ignoring the same signal Wall Street ignored in 1929?In 1929, Irving Weiss spotted a systemic crisis hiding beneath record highs and shorted the market - turning $...Weiss Ratings | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored24hrs Can Ruin Everything! 401(k) Owners BewareSpirit Airlines flew for over 30 years before abruptly ceasing all operations on May 2, 2026. When it emerged ...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Animalcare Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Animalcare Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
